Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 69680-130

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 69680-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vitruvias Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Propafenone Hydrochloride Extended-release Capsules, Usp 225 mg Bottle Label (225 500)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 225 mg, oral dosage form. The label indicates a bottle containing 500 capsules, manufactured for Vitruvias Therapeutics. The label includes a barcode, NDC 69680-130-92, and storage instructions, with warnings to keep out of reach of children and to check the seal on the bottle opening.*

FDA Label Image

Propafenone Hydrochloride Extended-release Capsules, Usp 225 mg Bottle Label (225 60)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 225 mg, oral dosage form. The label shows the product name, strength, and quantity of 60 capsules. It is labeled for prescription use only and manufactured for Vitruvias Therapeutics, Auburn, AL. The label includes storage instructions, content details, and a barcode.*

FDA Label Image

Propafenone Hydrochloride Extended-release Capsules, Usp 325 mg Bottle Label (325 500)

Label for Propafenone Hydrochloride Extended-Release Capsules USP 325 mg by Vitruvias Therapeutics. The label indicates 500 capsules per container, with dosage strength and route oral. It includes storage instructions, cautions about the seal and child safety, and manufacturer details.*

FDA Label Image

Propafenone Hydrochloride Extended-release Capsules, Usp 325 mg Bottle Label (325 60)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 325 mg by Vitruvias Therapeutics. The label details a package containing 60 capsules for oral use, with storage instructions and warnings. It includes a barcode, manufacturer information, and notes the product is for prescription use only.*

FDA Label Image

Propafenone Hydrochloride Extended-release Capsules, Usp 425 mg Bottle Label (425 500)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 425 mg by Vitruvias Therapeutics. The label displays the strength 425 mg prominently, with a package count of 500 capsules. It notes the product is Rx only, includes storage instructions, and states manufacturing by Vitruvias Therapeutics, Auburn, AL.*

FDA Label Image

Propafenone Hydrochloride Extended-release Capsules, Usp 425 mg Bottle Label (425 60)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 425 mg by Vitruvias Therapeutics. The package contains 60 capsules for oral use. The label includes storage instructions, a barcode, and manufacturer details indicating it is made in China and distributed by Vitruvias Therapeutics, Auburn, AL.*

FDA Label Image

Figure 1. Raft Kaplan-meier Analysis For The Tachycardia-free Period From Day 1 Of Randomization (Figure 01)

A Kaplan-Meier survival curve chart showing the proportion of patients without events over time (up to 300 days) for propafenone extended-release capsules at 225 mg, 325 mg, and 425 mg doses compared to placebo. The graph includes patient counts at risk at various time points and indicates statistically significant differences (p < 0.05) between treatment groups and placebo.*

FDA Label Image

Propafenone Hydrochloride Structural Formula (Structure 01)

Chemical structure diagram of propafenone hydrochloride, the active ingredient in Propafenone Hydrochloride capsules. The diagram shows the molecular arrangement relevant to the compound's chemical identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.